Helix BioPharma Corporation

This company was established in 1995 and it is a biopharmaceutical company aimed on the area of cancer therapy. They are actively developing products for the treatment and prevention of cancer based on its proprietary technologies.They use DOS Platform Technology and BiPhasix Technology. They offer many products but Helix’s most advanced product clinically is its Topical Interferon Alpha-2b as a treatment for certain skin/mucosal lesions caused by HPV infections.

Moreover, their business strategy is based on commercialization the drug products that they develop ona a royalty-bearing basis via third-party licensing arrangements, a strategy demonstrated with their first successfully launched product -Klean-Prep.